pregabalin (Lyrica) + pregabalin (Lyrica) + pregabalin (Lyrica)
Pre-clinicalCompleted 1 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Epilepsy
Conditions
Epilepsy, Neuropathic Pain, Fibromyalgia, Post-market Surveillance
Trial Timeline
Jul 1, 2006 → Apr 1, 2011
NCT ID
NCT01220180About pregabalin (Lyrica) + pregabalin (Lyrica) + pregabalin (Lyrica)
pregabalin (Lyrica) + pregabalin (Lyrica) + pregabalin (Lyrica) is a pre-clinical stage product being developed by Pfizer for Epilepsy. The current trial status is completed. This product is registered under clinical trial identifier NCT01220180. Target conditions include Epilepsy, Neuropathic Pain, Fibromyalgia.
What happened to similar drugs?
20 of 20 similar drugs in Epilepsy were approved
Approved (20) Terminated (6) Active (0)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01220180 | Pre-clinical | Completed |
Competing Products
20 competing products in Epilepsy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| perampanel | Eisai | Phase 2 | 35 |
| Lacosamide | UCB | Phase 3 | 40 |
| Zonisamide + Placebo | Eisai | Phase 3 | 32 |
| Zonegran | Eisai | Approved | 35 |
| perampanel + perampanel | Eisai | Phase 1 | 29 |
| Perampanel + Placebo | Eisai | Approved | 35 |
| perampanel | Eisai | Approved | 35 |
| E2007 + Placebo | Eisai | Phase 2 | 35 |
| Placebo + Rufinamide | Eisai | Phase 3 | 40 |
| E2007 (perampanel) + Placebo | Eisai | Phase 2 | 35 |
| Perampanel Oral Tablet | Eisai | Approved | 43 |
| perampanel | Eisai | Phase 3 | 40 |
| Perampanel | Eisai | Pre-clinical | 26 |
| Zonisamide + Carbamazepine | Eisai | Phase 3 | 40 |
| Perampanel | Eisai | Approved | 43 |
| Perampanel and Microgynon-30 + Perampanel and Microgynon-30 | Eisai | Phase 1 | 29 |
| Perampanel | Eisai | Phase 2 | 35 |
| Zonisamide + Placebo | Eisai | Phase 3 | 40 |
| zonisamide low dose group + zonisamide high dose group | Eisai | Approved | 43 |
| E2007 + E2007 + Placebo | Eisai | Phase 2 | 35 |